Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RUN

What Does the Market Think of Sunrun (RUN) Shares?

Shares of Sunrun fell to $12.47 during today's afternoon trading session. Despite the -2.9% change, the Mid-Cap Solar company still trades 5.29% above its average analyst target price of $11.85. So there may be further downside for the Solar stock. Sunrun has target prices ranging from $6.0 to $20.0 per share, and its average rating is buy.

The stock has an unusually large proportion of its shares sold short at 34.2%, and a short ratio of 5.01. Since 9.38% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 108.3% of Sunrun's shares being owned by this investor type.

Institutions Invested in Sunrun

Date Reported Holder Percentage Shares Value
2025-03-31 Blackrock Inc. 18% 41,126,530 $513,053,477
2025-03-31 Vanguard Group Inc 10% 23,443,442 $292,456,947
2025-03-31 Greenvale Capital, LLP 7% 15,150,116 $188,997,702
2025-03-31 Grantham, Mayo, Van Otterloo & Co. LLC 5% 11,530,856 $143,847,432
2025-03-31 Dimensional Fund Advisors LP 4% 9,942,198 $124,028,923
2025-03-31 State Street Corporation 4% 9,115,288 $113,713,221
2025-03-31 Morgan Stanley 3% 7,631,150 $95,198,599
2025-03-31 Invesco Ltd. 3% 6,762,720 $84,364,934
2024-12-31 Sylebra Capital LLC 3% 6,683,162 $83,372,448
2025-03-31 UBS Group AG 3% 6,223,256 $77,635,120

Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on Sunrun.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS